Clinical Trials Directory

Trials / Completed

CompletedNCT03244280

A Study of the Systemic Absorption of MOB015B

A Study of the Systemic Absorption of Once Daily MOB015B When Applied for 28 Days in Subjects With Moderate to Severe Onychomycosis of the Toenails.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Moberg Pharma AB · Industry
Sex
All
Age
12 Years – 70 Years
Healthy volunteers
Not accepted

Summary

A Study of the Systemic Absorption of Once Daily MOB015B when Applied for 28 Days in Subjects with Moderate to Severe Onychomycosis of the Toenails.

Conditions

Interventions

TypeNameDescription
DRUGMOB015BTopical formulation

Timeline

Start date
2017-12-16
Primary completion
2018-04-23
Completion
2018-04-23
First posted
2017-08-09
Last updated
2018-05-03

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03244280. Inclusion in this directory is not an endorsement.

A Study of the Systemic Absorption of MOB015B (NCT03244280) · Clinical Trials Directory